Medical technology company Healthcare Holding Schweiz AG announced on Monday that it has completed the acquisition of Effectum CH-Rep AG, effectively carving out all Swiss Authorized Representative (CH-REP) services from Effectum Medical AG.
Under the Medical Devices Ordinance (MedDO SR 812.213), medical device manufacturers without a Swiss presence must appoint a CH-REP to distribute products within Switzerland.
This acquisition enhances Healthcare Holding Schweiz AG's ability to serve as a comprehensive partner for global medical technology manufacturers. The company's expanded portfolio now includes services ranging from import and distribution to full regulatory compliance. This positions Healthcare Holding Schweiz AG to offer integrated solutions to meet evolving industry needs.
Mindray unveils BeneVision V Series at Euroanaesthesia 2025, advancing precision monitoring
Unicon Pharma and VRR Life Sciences partner support digital transformation in life sciences
Median Technologies submits 510(k) application for eyonis LCS lung cancer screening software
Tristel secures FDA clearance for Ophthalmic Disinfectant Tristel OPH
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)
Coologics' seed funding round raises over USD3m
DDL opens new GMP laboratory for drug-device combination product testing
Abbott receives CE Mark for Volt Pulsed Field Ablation System to treat atrial fibrillation
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA
Qlife secures UK approval to initiate clinical trial for Egoo Phe System